F

Fennec Pharmaceuticals Inc
TSX:FRX

Watchlist Manager
Fennec Pharmaceuticals Inc
TSX:FRX
Watchlist
Price: 10.39 CAD Market Closed
Market Cap: 283.9m CAD

Wall Street
Price Targets

FRX Price Targets Summary
Fennec Pharmaceuticals Inc

Wall Street analysts forecast FRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FRX is 19.53 CAD with a low forecast of 18.63 CAD and a high forecast of 22.34 CAD.

Lowest
Price Target
18.63 CAD
79% Upside
Average
Price Target
19.53 CAD
88% Upside
Highest
Price Target
22.34 CAD
115% Upside
Fennec Pharmaceuticals Inc Competitors:
Price Targets
FYB
Formycon AG
111% Upside
6855
Ascentage Pharma Group International
88% Upside
300676
BGI Genomics Co Ltd
28% Upside
603087
Gan & Lee Pharmaceuticals
4% Downside
688105
Nanjing Vazyme Biotech Co Ltd
43% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
50% Upside
TECX
AVROBIO Inc
317% Upside
1801
Innovent Biologics Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Fennec Pharmaceuticals Inc

The compound annual growth rate of Fennec Pharmaceuticals Inc's revenue for the next 4 years is 30%.

N/A
Past Growth
30%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Fennec Pharmaceuticals Inc

The compound annual growth rate of Fennec Pharmaceuticals Inc's operating income for the next 4 years is 121%.

N/A
Past Growth
121%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Fennec Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FRX's stock price target?
Price Target
19.53 CAD

According to Wall Street analysts, the average 1-year price target for FRX is 19.53 CAD with a low forecast of 18.63 CAD and a high forecast of 22.34 CAD.

What is Fennec Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
30%

The compound annual growth rate of Fennec Pharmaceuticals Inc's revenue for the next 4 years is 30%.

What is Fennec Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
121%

The compound annual growth rate of Fennec Pharmaceuticals Inc's operating income for the next 4 years is 121%.

Back to Top